- Home
- CYH vs ENGN Comparison
CYH vs ENGN Comparison
Compare CYH & ENGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CYH
- ENGN
- Stock Information
- Founded
- CYH 1985
- ENGN 1999
- Country
- CYH United States
- ENGN Canada
- Employees
- CYH N/A
- ENGN N/A
- Industry
- CYH Hospital/Nursing Management
- ENGN
- Sector
- CYH Health Care
- ENGN
- Exchange
- CYH Nasdaq
- ENGN Nasdaq
- Market Cap
- CYH 362.0M
- ENGN 297.7M
- IPO Year
- CYH 1991
- ENGN N/A
- Fundamental
- Price
- CYH $3.50
- ENGN $2.96
- Analyst Decision
- CYH Hold
- ENGN Buy
- Analyst Count
- CYH 8
- ENGN 7
- Target Price
- CYH $4.02
- ENGN $23.29
- AVG Volume (30 Days)
- CYH 3.4M
- ENGN 49.1K
- Earning Date
- CYH 04-23-2025
- ENGN 06-13-2025
- Dividend Yield
- CYH N/A
- ENGN N/A
- EPS Growth
- CYH N/A
- ENGN N/A
- EPS
- CYH N/A
- ENGN N/A
- Revenue
- CYH $12,653,000,000.00
- ENGN N/A
- Revenue This Year
- CYH N/A
- ENGN N/A
- Revenue Next Year
- CYH $4.15
- ENGN N/A
- P/E Ratio
- CYH N/A
- ENGN N/A
- Revenue Growth
- CYH 1.05
- ENGN N/A
- 52 Week Low
- CYH $2.24
- ENGN $3.27
- 52 Week High
- CYH $6.29
- ENGN $14.67
- Technical
- Relative Strength Index (RSI)
- CYH 74.92
- ENGN 21.28
- Support Level
- CYH $2.77
- ENGN $3.51
- Resistance Level
- CYH $2.94
- ENGN $3.99
- Average True Range (ATR)
- CYH 0.21
- ENGN 0.41
- MACD
- CYH 0.11
- ENGN -0.04
- Stochastic Oscillator
- CYH 92.06
- ENGN 1.38
About CYH Community Health Systems Inc.
Community Health Systems Inc is a publicly owned hospital operator in the United States. The company also owns four home health agencies and provides management and consulting services to independent hospitals. The firm derives revenue through a broad range of general and specialized hospital healthcare services and outpatient services.
About ENGN enGene Holdings Inc.
enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.